These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8688215

  • 1. [Cancers of the base of the tongue and hypopharynx: results of a multicenter randomized trial of chemotherapy prior to locoregional treatment].
    Gedouin D, Desprez P, Perron JJ, Fleury F, Leclech G, Miglianico L, Belpomme D, Chenal C.
    Bull Cancer Radiother; 1996; 83(2):104-7. PubMed ID: 8688215
    [Abstract] [Full Text] [Related]

  • 2. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
    Bensadoun RJ, Bénézery K, Dassonville O, Magné N, Poissonnet G, Ramaïoli A, Lemanski C, Bourdin S, Tortochaux J, Peyrade F, Marcy PY, Chamorey E, Vallicioni J, Seng H, Alzieu C, Géry B, Chauvel P, Schneider M, Santini J, Demard F, Calais G.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):983-94. PubMed ID: 16376489
    [Abstract] [Full Text] [Related]

  • 3. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J, Bocciolini C, Fournier C, Penel N, Kara A, Van JT, Lefebvre JL.
    Bull Cancer; 2002 Apr 15; 89(4):411-7. PubMed ID: 12016041
    [Abstract] [Full Text] [Related]

  • 4. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC).
    Domenge C, Hill C, Lefebvre JL, De Raucourt D, Rhein B, Wibault P, Marandas P, Coche-Dequeant B, Stromboni-Luboinski M, Sancho-Garnier H, Luboinski B, French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC).
    Br J Cancer; 2000 Dec 15; 83(12):1594-8. PubMed ID: 11189100
    [Abstract] [Full Text] [Related]

  • 5. [Preliminary results of a prospective randomized study of primary chemotherapy in carcinoma of the oral cavity and pharynx].
    Volling P, Schröder M.
    HNO; 1995 Feb 15; 43(2):58-64. PubMed ID: 7713766
    [Abstract] [Full Text] [Related]

  • 6. [Perioperative chemotherapy of squamous cell carcinoma of the hypopharynx].
    Mamelle G, Domenge C, Eschwège F, Leridant AM, Luboinski B, Wibault P.
    Bull Cancer Radiother; 1996 Feb 15; 83(2):115-7. PubMed ID: 8688218
    [Abstract] [Full Text] [Related]

  • 7. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS, Chung WK, Ahn SJ, Nam TK, Nah BS, Song JY, Lim SC, Lee JK.
    Acta Otolaryngol; 2008 May 15; 128(5):590-6. PubMed ID: 18421617
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.
    Semrau R, Mueller RP, Stuetzer H, Staar S, Schroeder U, Guntinas-Lichius O, Kocher M, Eich HT, Dietz A, Flentje M, Rudat V, Volling P, Schroeder M, Eckel HE.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1308-16. PubMed ID: 16464538
    [Abstract] [Full Text] [Related]

  • 9. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
    Altundag O, Gullu I, Altundag K, Yalcin S, Ozyar E, Cengiz M, Akyol F, Yucel T, Hosal S, Sozeri B.
    Head Neck; 2005 Jan 01; 27(1):15-21. PubMed ID: 15515158
    [Abstract] [Full Text] [Related]

  • 10. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct 01; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 11. [Current role for induction chemotherapy in head and neck tumors].
    Dietz A, Keilholz U, Werner J, Hagen R, Flentje M, Iro H.
    Laryngorhinootologie; 2008 Apr 01; 87(4):237-43; discussion 244. PubMed ID: 18365986
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant therapy for organ preservation in head and neck cancer.
    Urba SG, Wolf GT, Bradford CR, Thornton AF, Eisbruch A, Terrell JE, Carpenter V, Miller T, Tang G, Strawderman M.
    Laryngoscope; 2000 Dec 01; 110(12):2074-80. PubMed ID: 11129024
    [Abstract] [Full Text] [Related]

  • 13. [Antineoplastic effectiveness and unwanted side effects of polychemotherapy of extensive oro- and hypopharyngeal cancers--results of a prospective therapy study with 5-FU/cisplatin versus 5-FU/carboplatin].
    Welkoborsky HJ, Bleier R, Wissen-Siegert I.
    Laryngorhinootologie; 1992 May 01; 71(5):261-6. PubMed ID: 1616547
    [Abstract] [Full Text] [Related]

  • 14. [Cytostatic primary therapy of squamous cell carcinoma of the oro- and hypopharynx with cisplatin, bleomycin and methotrexate].
    Deitmer T, Urbanitz D.
    Laryngol Rhinol Otol (Stuttg); 1986 Jan 01; 65(1):7-10. PubMed ID: 2419720
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of concomitant radiotherapy and chemotherapy with radiotherapy alone in advanced cancers of the head and neck: results of a randomized trial].
    Haddad E, Mazeron JJ, Martin M, Vergnes L, Brun B, Piedbois P, Coste A, Lelievre G, Peynegre R, Le Bourgeois JP.
    Bull Cancer Radiother; 1996 Jan 01; 83(2):97-103. PubMed ID: 8688226
    [Abstract] [Full Text] [Related]

  • 16. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT, Sham JS, Choy D, Lorvidhaya V, Sumitsawan Y, Thongprasert S, Vootiprux V, Cheirsilpa A, Azhar T, Reksodiputro AH.
    Cancer; 1998 Dec 01; 83(11):2270-83. PubMed ID: 9840526
    [Abstract] [Full Text] [Related]

  • 17. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
    Zelefsky MJ, Kraus DH, Pfister DG, Raben A, Shah JP, Strong EW, Spiro RH, Bosl GJ, Harrison LB.
    Head Neck; 1996 Dec 01; 18(5):405-11. PubMed ID: 8864731
    [Abstract] [Full Text] [Related]

  • 18. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
    Urba SG, Moon J, Giri PG, Adelstein DJ, Hanna E, Yoo GH, Leblanc M, Ensley JF, Schuller DE.
    J Clin Oncol; 2005 Jan 01; 23(1):88-95. PubMed ID: 15625363
    [Abstract] [Full Text] [Related]

  • 19. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
    Lee MS, Ho HC, Hsiao SH, Hwang JH, Lee CC, Hung SK.
    Acta Otolaryngol; 2008 Jan 01; 128(1):103-9. PubMed ID: 17851955
    [Abstract] [Full Text] [Related]

  • 20. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G, Tsukuda M, Horiuchi C, Satake K, Yoshida T, Nagao J, Kawakami M, Kondo N, Arai Y, Taguchi T, Matsuda H, Mikami Y.
    Auris Nasus Larynx; 2007 Dec 01; 34(4):499-504. PubMed ID: 17604583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.